Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Total Liabilities: 2021-2025

Historic Total Liabilities for Prime Medicine (PRME) over the last 4 years, with Sep 2025 value amounting to $223.2 million.

  • Prime Medicine's Total Liabilities rose 55.77% to $223.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $223.2 million, marking a year-over-year increase of 55.77%. This contributed to the annual value of $144.4 million for FY2024, which is 137.51% up from last year.
  • Latest data reveals that Prime Medicine reported Total Liabilities of $223.2 million as of Q3 2025, which was up 2.31% from $218.1 million recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's Total Liabilities registered a high of $223.2 million during Q3 2025, and its lowest value of $38.1 million during Q1 2023.
  • Moreover, its 3-year median value for Total Liabilities was $67.6 million (2024), whereas its average is $115.1 million.
  • Per our database at Business Quant, Prime Medicine's Total Liabilities plummeted by 79.10% in 2023 and then surged by 245.63% in 2025.
  • Prime Medicine's Total Liabilities (Quarterly) stood at $62.3 million in 2021, then fell by 29.30% to $44.0 million in 2022, then surged by 38.00% to $60.8 million in 2023, then surged by 137.51% to $144.4 million in 2024, then skyrocketed by 55.77% to $223.2 million in 2025.
  • Its Total Liabilities stands at $223.2 million for Q3 2025, versus $218.1 million for Q2 2025 and $221.2 million for Q1 2025.